相关实验视频
Updated: May 22, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
中细胞干细胞衍生的外体在癌症中对治疗药物的抵抗力
Vignesh Balaji Easwaran1, K Maya S Pai2, K Sreedhara Ranganath Pai1
1Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India.
介质干细胞 (MSC) 和它们的外体细胞 (MSC-Exos) 可以在各种癌症中意外地促进瘤生长和耐治疗性. 本综述详细介绍了癌症进展中这种双重作用背后的生物标志物和机制.
科学领域:
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 介酶干细胞 (MSCs) 具有多能分化能力.
- MSCs被用于癌症治疗,但表现出双重作用,可能促进瘤的进展.
- 由MSC衍生的外体细胞 (MSC-Exos) 调解细胞间通信,并影响癌症生物学.
研究的目的:
- 阐明MSC-Exos有助于瘤进展的机制.
- 研究MSC-Exos在调解抗癌疗法的作用.
- 确定与MSC-Exo驱动的瘤和耐药性发展相关的生物标志物.
主要方法:
- 对MSC,MSC-Exos和癌症研究的文献综述.
- 分析MSC-Exos.的瘤促进背后的机制.
- 检查涉及MSC-Exos诱导的治疗耐药性的途径.
主要成果:
- MSC-Exos促进各种癌症的瘤进展,包括大脑,乳腺,肝脏,肺癌和结直肠癌.
- MSC-Exos有助于抵抗化疗,放射治疗和免疫治疗.
- 癌细胞异质性影响MSC-Exo介导的耐药性机制.
结论:
- MSC-Exos在癌症的进展和治疗耐药性的发展中发挥着重要作用.
- 了解特定的生物标志物和机制对于开发向癌症治疗至关重要.
- 对MSC-Exo功能的进一步研究可以导致新的治疗策略.
更多相关视频
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
相关概念视频
Mesenchymal Stem Cells
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Treatment Resistant Cancers
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment